Integrative molecular characterisation of S/R RCC to reveal determinants of poor...
Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or ...
Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020
NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advan...
Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom
NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer ( Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom )
18 Feb 2020
OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients
Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec
OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients ( Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec )
18 Feb 2020
ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and no...
Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob
ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and novel agents ( Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob )
14 Feb 2020
Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer
Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston, ...
Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer ( Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston, USA )
14 Feb 2020
BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant tre...
Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA
BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle invasive bladder cancer ( Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA )
14 Feb 2020
Management of patients with advanced seminoma
Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany
Management of patients with advanced seminoma ( Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany )
14 Feb 2020
CHHip: Conventional versus hypofractionated high-dose intensity modulated radiot...
Prof David Dearnaley - Institute of Cancer Research, London, UK
CHHip: Conventional versus hypofractionated high-dose intensity modulated radiotherapy for localised prostate cancer ( Prof David Dearnaley - Institute of Cancer Research, London, UK )
14 Feb 2020
Latest advances in mHSPC from ASCO GU 2020
Dr Eleni Efstathiou and Prof Axel Merseburger
Latest advances in mHSPC from ASCO GU 2020 ( Dr Eleni Efstathiou and Prof Axel Merseburger )
14 Feb 2020
ASCO GU 2020: Updates in renal cancer
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2020
Beyond p-values: When does clinical impact outweigh statistical significance?
Prof Matthew Sydes - University College London, London, UK
Beyond p-values: When does clinical impact outweigh statistical significance? ( Prof Matthew Sydes - University College London, London, UK )
14 Feb 2020